You are searching for: hsa04210

---

T99149 Target Info	Target Name	HUMAN ERK activator kinase 2 (MEK2)
	Target type	. Target
	Disease	Metastatic melanoma; Neurofibromatosis type 1;
	Drugs	Trametinib	Drug Info

T35940 Target Info	Target Name	ERK activator kinase 1 (MEK1)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T67619 Target Info	Target Name	RAC-alpha serine/threonine-protein kinase (AKT1)
	Target type	Successful Target
	Disease	Triple negative breast cancer; Colorectal cancer;
	Drugs	Capivasertib	Drug Info

T67102 Target Info	Target Name	Cathepsin D (CTSD)
	Target type	Clinical trial Target
	Disease	Multiple sclerosis; Hypertension;
	Drugs	PMID10498202C1	Drug Info

T11388 Target Info	Target Name	Cathepsin K (CTSK)
	Target type	Clinical trial Target
	Disease	Bone cancer; Chronic obstructive pulmonary disease;
	Drugs	Odanacatib	Drug Info

T89055 Target Info	Target Name	ERK activator kinase 2 (MEK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T58970 Target Info	Target Name	Extracellular signal-regulated kinase 2 (ERK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Artery stenosis;
	Drugs	BVD-523	Drug Info

T78429 Target Info	Target Name	Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
	Target type	Clinical trial Target
	Disease	Acute lymphoblastic leukaemia; Alzheimer disease;
	Drugs	Arsenic trioxide	Drug Info

T71266 Target Info	Target Name	RAC-gamma serine/threonine-protein kinase (AKT3)
	Target type	Successful Target
	Disease	Breast cancer; Triple negative breast cancer;
	Drugs	Capivasertib	Drug Info

T40097 Target Info	Target Name	Stress-activated protein kinase JNK1 (JNK1)
	Target type	Clinical trial Target
	Disease	Solid tumour/cancer; T-cell leukaemia;
	Drugs	NKP-1339	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.